VectorBuilder

VectorBuilder is a global leader in gene delivery technologies, offering a full spectrum of gene delivery solutions for research and clinical needs from bench to bedside. With a mission to provide end-to-end solutions for all gene delivery needs, VectorBuilder focuses on innovative, high-quality products and services, maintaining rapid turnaround and exceptional affordability. Supported by a team with decades of collective experience, they have received glowing customer testimonials and numerous citations in high-impact publications. Operating as a multinational company with branches across North America, Europe, China, Japan, South Korea, Australia, and Israel, VectorBuilder has served over 50,000 customers from thousands of organizations worldwide. Founded in 2015, the company operates in the biotechnology and e-commerce industries, with its headquarters in the United States. Its most recent Venture Round investment occurred on 23 May 2023. As VectorBuilder continues to revolutionize gene delivery, it presents an intriguing opportunity for potential investors to consider.